Why Life Sciences needs reusable data products, not one-off analytics
Published: Oct 8th, 2026
Life Sciences organizations have access to more data than ever, spanning research, clinical development, medical affairs, commercial operations, and real-world evidence analytics. But having access to data does not automatically create a reusable data capability.
The variety of platforms in Life Sciences data architectures can make analytics work repetitive, labor-intensive, expensive, and time-consuming. Data products can help organizations make greater use of their existing data by creating specialized, reusable assets that support multiple domains and use cases.
This points to a problem that is easy to overlook. An organization can be rich in data and still spend too much time preparing that data every time a new question emerges. The challenge is not simply generating more analytics. It is building data capabilities that become more useful with reuse.
One-off analytics creates duplication that compounds over time
When data engineering is organized around individual projects, teams often build pipelines, transformations, and analytical datasets for a specific study, product, indication, or business question.
The immediate requirement may be met, but the underlying work is not always easy to reuse. A dataset assembled for one clinical program may use different definitions from a similar dataset elsewhere in the organization. A commercial analysis may require another set of transformations. A real-world evidence dataset may remain within the team that originally commissioned it.
Over time, this creates a familiar pattern: similar data is prepared repeatedly, definitions are reconciled again, and engineering teams spend time rebuilding foundations that already exist in some form.
The cost is not limited to engineering effort. Repeated preparation can make it harder for teams to compare insights, slow down new analysis, and increase the maintenance burden across the data estate.
The alternative is to treat each new analytical requirement as an opportunity to build something that can support the next question too.
A data product is a reusable capability, not simply a dataset
That requires a shift in how organizations think about data. A conventional analytical dataset is often created to answer a particular question. A data product is designed to be used repeatedly.
Life Sciences data products can be thought of as specialized and reusable data assets created from raw data. These products can standardize data, enable reuse across business units, streamline integration, and reduce redundancy. The distinction is important because a data product needs more than data that has been cleaned and made available. It needs a defined purpose and identifiable users. It needs clear ownership, consistent definitions, appropriate quality expectations, and a way for users to understand where the data came from and how it can be used. It also needs to be maintained as the underlying data and business requirements change.
In other words, the product is not simply the dataset. It is the combination of data, engineering, governance, and the experience required to make that data consistently useful.
Reusable data products need a common engineering foundation
Building reusable data products does not mean every function should create its own technology stack. R&D, commercial, and medical affairs may have different data requirements and domain expertise, but the technical foundations supporting their data products can still be shared. Capabilities such as scalable storage and compute, workflow management, data cataloging and governance, and continuous integration and delivery can provide a common foundation for building and maintaining data products.
This creates an important balance between domain ownership and shared infrastructure.
A clinical development team may own the logic and definitions required for a particular data product. A commercial team may own a different product built around its own business questions. Both can use common capabilities for access, security, deployment, cataloging, and data quality.
The benefit is not standardization for its own sake. It is creating enough consistency that data products can work together and be reused without every team having to solve the same engineering problems independently.
This is where product engineering becomes important. The objective is to create a foundation that makes it easier for domain teams to build, publish, consume, and evolve data products without creating another layer of disconnected systems.
Build data products around recurring business questions, not individual projects
The strongest case for reusable data products is what happens after the first use. A data capability designed around a recurring business need can support multiple questions over time, across teams or therapeutic areas, instead of being tied to a single analytical request.
Research on scaling real-world evidence analytics describes data engineers creating reusable data pipelines and analytics product teams building reusable modular software and data products that can be configured for new therapeutic areas and business units. The approach is intended to help organizations scale evidence generation across indications, therapies, and use cases.
The same principle can apply across the broader Life Sciences value chain, including clinical trial data analytics and other recurring analytical needs. A well-designed longitudinal patient data product, for example, could support different analytical needs across clinical development, medical affairs, and commercial teams, provided the relevant governance, access, and methodological requirements are addressed.
The important question therefore changes from "What dataset do we need for this project?" to "What capability will we need repeatedly, and how should we engineer it so others can use it too?". That shift is what turns data reuse into an enterprise capability.
Data products need product management and an ongoing lifecycle
A reusable data product should not be considered finished when the first pipeline is delivered. Applying software development and product management practices can help data products evolve over time, including modularization, testing, agile development, product ownership, road maps, and ongoing collaboration with data consumers. The implication for data teams is significant.
Instead of operating primarily as a service function that responds to individual requests, teams responsible for data products need to understand who uses their products, how those products are performing, and what needs to change over time. That means tracking more than whether a dataset was delivered. Adoption, data quality, reliability, user needs, and the ability to support new use cases all become part of the product lifecycle.
The result is a data asset that can evolve with the organization rather than becoming another legacy pipeline that needs to be rebuilt when requirements change.
Reusable data products can become the foundation for scalable analytics and AI
The value of this approach ultimately extends beyond reducing duplicated engineering work. Reusable data products create a more consistent foundation for analytics, machine learning, and AI because downstream applications can work from data that has already been structured, governed, and designed for repeated use.
McKinsey estimates that, on average, a top-20 pharmaceutical company could unlock more than $300 million a year over the next three to five years by adopting advanced real-world evidence analytics across its value chain. Its research also emphasizes the need for an integrated data environment, reusable data pipelines, technical platforms, and analytics product teams to scale these capabilities across indications, therapies, and use cases.
The opportunity, then, is not to build more analytical pipelines every time a new question emerges. It is to build data capabilities that can support many questions.
For Life Sciences organizations, that means treating data products as enduring technology assets, with the engineering, ownership, and governance required to make them reusable over time. Product engineering provides the bridge between fragmented data assets and those reusable capabilities, helping organizations create foundations that can support changing business questions across the value chain.
About us
Reveal HealthTech partners with leading Life Sciences, biotech, and healthcare organizations to design custom workflow-native platforms, modernize data engineering architectures, and build scalable, product-engineered data foundations.
Are you ready to move past one-off analytics pipelines and build reusable data products that drive enterprise execution? Connect with our technology directors at hello@revealhealthtech.com or visit our Contact Us page to schedule a strategic discussion.
